STMC-103H

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSTMC-103H
Drug Alias NameSTMC-103H
ClassificationNatural product/Extract > Microbial extractBiologics
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSiolta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSiolta Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHypersensitivityDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A